| Serial Number | 86587871 |
| Word Mark | VIRTUS |
| Filing Date | Monday, April 6, 2015 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Friday, September 8, 2023 |
| Registration Number | 5111954 |
| Registration Date | Tuesday, January 3, 2017 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 18, 2016 |
| Goods and Services | Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia |
| Goods and Services | Distributorship services in the field of prescription and over-the-counter drugs; marketing of prescription and over-the-counter drugs |
| Goods and Services | Development of pharmaceutical products |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 14, 2015 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, October 1, 2011 |
| First Use In Commerce Date | Saturday, October 1, 2011 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 14, 2015 |
| Primary Code | 035 |
| First Use Anywhere Date | Saturday, October 1, 2011 |
| First Use In Commerce Date | Saturday, October 1, 2011 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 14, 2015 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, October 1, 2011 |
| First Use In Commerce Date | Saturday, October 1, 2011 |
| Party Name | Virtus Pharmaceuticals, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Newtown, PA 18940 |
| Party Name | Virtus Pharmaceuticals, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Tampa, FL 33619 |
| Party Name | Virtus Pharmaceuticals, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Tampa, FL 33619 |
| Event Date | Event Description |
| Friday, September 8, 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Friday, September 8, 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Friday, September 8, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, March 10, 2023 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, January 3, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, January 11, 2017 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, January 11, 2017 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, January 3, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 18, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 18, 2016 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 28, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 14, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, September 1, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 31, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, August 31, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 31, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 31, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 15, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 15, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 13, 2016 | ASSIGNED TO LIE |
| Friday, August 5, 2016 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, August 4, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 4, 2016 | PETITION TO REVIVE-GRANTED |
| Thursday, August 4, 2016 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, July 18, 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, July 18, 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 3, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 3, 2016 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 3, 2016 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 20, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 20, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 20, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 21, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 21, 2015 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 21, 2015 | NON-FINAL ACTION WRITTEN |
| Monday, July 20, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 20, 2015 | NON-FINAL ACTION E-MAILED |
| Monday, July 20, 2015 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 14, 2015 | ASSIGNED TO EXAMINER |
| Thursday, April 30, 2015 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Thursday, April 30, 2015 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, April 14, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 9, 2015 | NEW APPLICATION ENTERED |